Personnel

Vogel named to biotech company's board of directors

Published in Drug Week, February 13th, 2004

Boston Biomedica, Inc., (BBII) announced the appointment of P. Thomas Vogel to the company's board of directors effective January 9, 2004.

In addition, the company also announced that Vogel will serve on the board's audit and compensation committees. Vogel will fill the new Class II vacancy created by the unanimous decision by the company's board to expand its size from five to six members. The term for Class II members is set to expire at the 2004 annual meeting of stockholders.

Vogel is the president and CEO of AdipoGenix, Inc., an early-stage drug discovery company focusing on obesity and metabolic diseases, with a unique approach to directly...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-02-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry